Cargando…
A prediction model for 5-year cardiac mortality in patients with chronic heart failure using (123)I-metaiodobenzylguanidine imaging
PURPOSE: Prediction of mortality risk is important in the management of chronic heart failure (CHF). The aim of this study was to create a prediction model for 5-year cardiac death including assessment of cardiac sympathetic innervation using data from a multicenter cohort study in Japan. METHODS: T...
Autores principales: | Nakajima, Kenichi, Nakata, Tomoaki, Yamada, Takahisa, Yamashina, Shohei, Momose, Mitsuru, Kasama, Shu, Matsui, Toshiki, Matsuo, Shinro, Travin, Mark I., Jacobson, Arnold F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122818/ https://www.ncbi.nlm.nih.gov/pubmed/24663289 http://dx.doi.org/10.1007/s00259-014-2759-x |
Ejemplares similares
-
Validation of 2-year (123)I-meta-iodobenzylguanidine-based cardiac mortality risk model in chronic heart failure
por: Nakajima, Kenichi, et al.
Publicado: (2018) -
Creation of mortality risk charts using (123)I meta-iodobenzylguanidine heart-to-mediastinum ratio in patients with heart failure: 2- and 5-year risk models
por: Nakajima, Kenichi, et al.
Publicado: (2016) -
Is (123)I-metaiodobenzylguanidine heart-to-mediastinum ratio dependent on age? From Japanese Society of Nuclear Medicine normal database
por: Nakajima, Kenichi, et al.
Publicado: (2018) -
Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations
por: Nakajima, Kenichi, et al.
Publicado: (2014) -
Machine learning-based risk model using (123)I-metaiodobenzylguanidine to differentially predict modes of cardiac death in heart failure
por: Nakajima, Kenichi, et al.
Publicado: (2020)